-
Acceleron Pharma Inc., Cambridge, Mass. Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Musculoskeletal Acceleron said Shire terminated a 2010 deal that gave Shire exclusive rights outside North America to …
Published on 5/13/2013
-
Afraxis Inc., La Jolla, Calif. Servier, Neuilly-sur-Seine, France Business: Neurology The partners will use Afraxis' Enhanced Spine Platform (ESP) technology to discover treatments for CNS disorders. Afraxis' EPS …
Published on 5/13/2013
-
Albion Medical Holdings Inc., Lenoir, N.C. Ares Life Sciences, Geneva, Switzerland Business: Inflammation Investment group Ares completed its acquisition of Albion, including wholly owned subsidiary Greer Laboratories …
Published on 5/13/2013
-
Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Neurology Alexza granted Teva exclusive, U.S. rights to Adasuve loxapine, …
Published on 5/13/2013
-
Allegro Ophthalmics LLC, San Juan Capistrano, Calif. Senju Pharmaceutical Co. Ltd., Osaka, Japan Business: Ophthalmic Allegro granted Senju exclusive rights to co-develop and market ALG-1001 in Japan to treat vascular …
Published on 5/13/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Transgenomic Inc. (OTCBB:TBIO), Omaha, Neb. Business: Diagnostic The companies will develop a CE Mark-approved test to screen metastatic colorectal cancer (mCRC) patients …
Published on 5/13/2013
-
Batavia Bioservices B.V., Leiden, the Netherlands University of Amsterdam, Amsterdam, the Netherlands Business: Biomanufacturing The university's UvA Holding B.V. commercial arm granted Batavia exclusive rights to …
Published on 5/13/2013
-
Bio-Matrix Scientific Group Inc. (OTCQB:BMSN; Pink:BMSN), La Mesa, Calif. University of Western Ontario, London, Ontario Business: Cancer Bio-Matrix's Regen BioPharma Inc. subsidiary completed the acquisition of a …
Published on 5/13/2013
-
BioHelix Corp., Beverly, Mass. Quidel Corp. (NASDAQ:QDEL), San Diego, Calif. Business: Diagnostic Quidel acquired BioHelix for $10 million in cash, plus R&D and commercial milestones based on the completion of a …
Published on 5/13/2013
-
BioView Ltd. (Tel Aviv:BIOV), Ness Ziona, Israel Kindstar Global Co. Ltd., Beijing, China Business: Diagnostic BioView and Kindstar partnered to conduct a Chinese pilot study of BioView's lung cancer detection kit. The …
Published on 5/13/2013
-
Bracco Diagnostics Inc., Princeton, N.J. Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. Business: Dermatology Emergent will acquire the Healthcare Protective Products Division (HPPD) of Bracco's Bracco …
Published on 5/13/2013
-
Celgene Corp. (NASDAQ:CELG), Summit, N.J. Concert Pharmaceuticals Inc., Lexington, Mass. Business: Cancer, Inflammation The companies partnered to develop deuterium-modified compounds for cancer and inflammation. The …
Published on 5/13/2013
-
Cellmid Ltd. (ASX:CDY), Sydney, Australia Advangen Inc., Japan Business: Other Cellmid acquired Advangen for 120 million ($1.2 million) in cash and 55.7 million shares valued at A$1.7 million ($1.7 million) based on …
Published on 5/13/2013
-
Co-Diagnostics Inc., Sandy, Utah DNA Logix Inc., Bountiful, Utah Business: Diagnostic Molecular diagnostic company Co-Diagnostics acquired undisclosed technology for genetic analysis from DNA Logix consisting of three …
Published on 5/13/2013
-
Conceptus Inc. (NASDAQ:CPTS), Mountain View, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Genitourinary Bayer's Bayer HealthCare LLC subsidiary began its tender offer to acquire Conceptus for $31 per …
Published on 5/13/2013
-
Constellation Diagnostics Inc., Cambridge, Mass. Tauriga Sciences Inc. (OTCQB:TAUG), Danbury, Conn. Business: Cancer The companies signed a memorandum of understanding to form a JV to develop and commercialize an …
Published on 5/13/2013
-
Debiopharm Group, Lausanne, Switzerland Oncotest GmbH, Freiburg, Germany Business: Cancer Debiopharm and Oncotest announced that they had identified several predictive biomarker candidates, including a gene signature to…
Published on 5/13/2013
-
Drais Pharmaceuticals Inc., Bridgewater, N.J. Tacurion Pharma Inc., Bridgewater, N.J. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Gastrointestinal Astellas and Drais partnered to form virtual company …
Published on 5/13/2013
-
Foundation Medicine Inc., Cambridge, Mass. Memorial Sloan-Kettering Cancer Center, New York, N.Y. Business: Pharmacogenetics Foundation and the cancer center will co-develop a molecular diagnostic product from …
Published on 5/13/2013
-
Full Spectrum Genetics Inc., South San Francisco, Calif. Business: Antibodies, Supply/Service Full Spectrum announced it received a milestone payment from an undisclosed pharma under a 2012 deal to engineer and analyze …
Published on 5/13/2013
-
Glide Pharma Technologies Ltd., Abingdon, U.K. Pfenex Inc., San Diego, Calif. Business: Infectious, Drug delivery Glide said it received a sub-contract from Pfenex to develop a solid formulation of Pfenex's recombinant …
Published on 5/13/2013
-
Hyperion Therapeutics Inc. (NASDAQ:HPTX), South San Francisco, Calif. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Montreal, Quebec Business: Endocrine/Metabolic Hyperion exercised its option under an…
Published on 5/13/2013
-
Ilika plc, Southampton, U.K. Regenerys Ltd., Cambridge, Mass. Business: Gene/Cell therapy Regenerative medicine company Regenerys acquired Ilika's Altrika Ltd. subsidiary in Sheffield, U.K. Altrika markets its cell-…
Published on 5/13/2013
-
Inverclyde Biologicals Ltd., Motherwell, U.K. Source BioScience plc (LSE:SBS), Nottingham, U.K. Business: Supply/Service, Diagnostic Diagnostics and genetic analysis company Source BioScience acquired Inverclyde …
Published on 5/13/2013
-
Inviragen Inc., Fort Collins, Colo. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Tokyo, Japan Business: Infectious Takeda will acquire infectious disease company Inviragen for $35 million in cash up front, plus up to $…
Published on 5/13/2013